evid specif effect serum patient cystic fibrosi sodiumdepend glucos transport rat jejunum sera patient cystic fibrosi pancrea cf normal human sera assay abil inhibit sodium depend glucos transport rat brushbord membran vesicl fresh cf age sexmatch control sera inhibitori compar physiolog salin inhibit cf serum 44 13 mean sd final serum concentr 67 67 34 10 serum 68 28 20 serum ratio inhibit cf sera compar control sera 100 078 093 67 10 20 serum concentr respect although slightli greater inhibit cf serum observ concentr 10 probabl signific differ could detect concentr 20 serum glucos transport presenc serum sensit phlorizin indic residu glucos transport proceed sodiumdepend glucos transport system find suggest cf serum specif inhibit sodiumdepend glucos transport system intravesicular space access glucos reduc presenc cf control serum fresh cf serum 14 time effect fresh control serum p less 001 presenc substanti vesicl shrink activ control serum indic activ cannot consid specif cf